Fas Promotes T Helper 17 Cell Differentiation and Inhibits T Helper 1 Cell Development by Binding and Sequestering Transcription Factor STAT1

[1]  Yuka Kanno,et al.  Mechanisms and consequences of Jak–STAT signaling in the immune system , 2017, Nature Immunology.

[2]  T. Korn,et al.  T cell responses in the central nervous system , 2017, Nature Reviews Immunology.

[3]  A. Regev,et al.  RBPJ Controls Development of Pathogenic Th17 Cells by Regulating IL-23 Receptor Expression. , 2016, Cell reports.

[4]  M. Veldhoen,et al.  Tbet or Continued RORγt Expression Is Not Required for Th17-Associated Immunopathology , 2016, The Journal of Immunology.

[5]  Youjin Lee,et al.  IL-21R signaling is critical for induction of spontaneous experimental autoimmune encephalomyelitis. , 2015, The Journal of clinical investigation.

[6]  V. Kuchroo,et al.  IL-27 Induces Th17 Differentiation in the Absence of STAT1 Signaling , 2015, The Journal of Immunology.

[7]  Rona S. Gertner,et al.  Single-Cell Genomics Unveils Critical Regulators of Th17 Cell Pathogenicity , 2015, Cell.

[8]  Y. Okamoto,et al.  Asymmetric Action of STAT Transcription Factors Drives Transcriptional Outputs and Cytokine Specificity. , 2015, Immunity.

[9]  D. Centonze,et al.  FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients , 2015, Cell Death and Disease.

[10]  Judith A. Blake,et al.  The Mouse Genome Database (MGD): facilitating mouse as a model for human biology and disease , 2014, Nucleic Acids Res..

[11]  Mark S. Sundrud,et al.  Small-molecule RORγt antagonists inhibit T helper 17 cell transcriptional network by divergent mechanisms. , 2014, Immunity.

[12]  E. Bettelli,et al.  Cutting Edge: The Pathogenicity of IFN-γ–Producing Th17 Cells Is Independent of T-bet , 2013, The Journal of Immunology.

[13]  A. Regev,et al.  Dynamic regulatory network controlling Th17 cell differentiation , 2013, Nature.

[14]  A. Regev,et al.  Induction and molecular signature of pathogenic TH17 cells , 2012, Nature Immunology.

[15]  Steven L Salzberg,et al.  Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.

[16]  A. Fischer,et al.  Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis , 2011, The Journal of experimental medicine.

[17]  O. Janssen,et al.  Modulation of CD4+ T-cell activation by CD95 co-stimulation , 2011, Cell Death and Differentiation.

[18]  M. Veldhoen,et al.  Fate mapping of interleukin 17-producing T cells in inflammatory responses , 2011, Nature Immunology.

[19]  Todd Davidson,et al.  Generation of Pathogenic Th17 Cells in the Absence of TGF-β Signaling , 2010, Nature.

[20]  N. Friedman,et al.  Comprehensive comparative analysis of strand-specific RNA sequencing methods , 2010, Nature Methods.

[21]  Cole Trapnell,et al.  Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. , 2010, Nature biotechnology.

[22]  W. Paul,et al.  Differentiation of effector CD4 T cell populations (*). , 2010, Annual review of immunology.

[23]  W. Paul,et al.  Mechanisms Underlying Lineage Commitment and Plasticity of Helper CD4+ T Cells , 2010, Science.

[24]  V. Kuchroo,et al.  Th1, Th17, and Th9 Effector Cells Induce Experimental Autoimmune Encephalomyelitis with Different Pathological Phenotypes1 , 2009, The Journal of Immunology.

[25]  Lionel B Ivashkiv,et al.  Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. , 2009, Immunity.

[26]  Lior Pachter,et al.  Sequence Analysis , 2020, Definitions.

[27]  Thomas Korn,et al.  IL-17 and Th17 Cells. , 2009, Annual review of immunology.

[28]  A. Strasser,et al.  The many roles of FAS receptor signaling in the immune system. , 2009, Immunity.

[29]  B. Becher,et al.  IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. , 2008, The Journal of clinical investigation.

[30]  Warren Strober,et al.  Interactions among the transcription factors Runx1, RORγt and Foxp3 regulate the differentiation of interleukin 17–producing T cells , 2008, Nature Immunology.

[31]  S. Tangye,et al.  Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3 , 2008, The Journal of experimental medicine.

[32]  W. Paul,et al.  Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome , 2008, Nature.

[33]  Hua Yu,et al.  Cutting Edge: An In Vivo Requirement for STAT3 Signaling in TH17 Development and TH17-Dependent Autoimmunity1 , 2007, The Journal of Immunology.

[34]  D. G. Zisoulis,et al.  Stat3 and Stat4 Direct Development of IL-17-Secreting Th Cells1 , 2007, The Journal of Immunology.

[35]  Chen Dong,et al.  STAT3 Regulates Cytokine-mediated Generation of Inflammatory Helper T Cells* , 2007, Journal of Biological Chemistry.

[36]  V. Kuchroo,et al.  Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice. , 2006, The Journal of clinical investigation.

[37]  S. Nakae,et al.  IL-17 Plays an Important Role in the Development of Experimental Autoimmune Encephalomyelitis1 , 2006, The Journal of Immunology.

[38]  H. Weiner,et al.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells , 2006, Nature.

[39]  Alexander E. Kel,et al.  TRANSFAC® and its module TRANSCompel®: transcriptional gene regulation in eukaryotes , 2005, Nucleic Acids Res..

[40]  R. Budd,et al.  The Death Receptor Fas (CD95/APO-1) Mediates the Deletion of T Lymphocytes Undergoing Homeostatic Proliferation1 , 2005, The Journal of Immunology.

[41]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[42]  F. Rieux-Laucat,et al.  Autoimmune lymphoproliferative syndrome with somatic Fas mutations. , 2004, The New England journal of medicine.

[43]  S. Szabo,et al.  Loss of T-bet, But Not STAT1, Prevents the Development of Experimental Autoimmune Encephalomyelitis , 2004, The Journal of experimental medicine.

[44]  K. Rajewsky,et al.  T Cell–specific Ablation of Fas Leads to Fas Ligand–mediated Lymphocyte Depletion and Inflammatory Pulmonary Fibrosis , 2004, The Journal of experimental medicine.

[45]  H. Weiner,et al.  Myelin Oligodendrocyte Glycoprotein–specific T Cell Receptor Transgenic Mice Develop Spontaneous Autoimmune Optic Neuritis , 2003, The Journal of experimental medicine.

[46]  R. Kastelein,et al.  Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain , 2003, Nature.

[47]  Y. Benjamini,et al.  THE CONTROL OF THE FALSE DISCOVERY RATE IN MULTIPLE TESTING UNDER DEPENDENCY , 2001 .

[48]  Ye Zheng,et al.  NF-κB RelA (p65) Is Essential for TNF-α-Induced Fas Expression but Dispensable for Both TCR-Induced Expression and Activation-Induced Cell Death1 , 2001, The Journal of Immunology.

[49]  Y. E. Chin,et al.  Stat1 as a Component of Tumor Necrosis Factor Alpha Receptor 1-TRADD Signaling Complex To Inhibit NF-κB Activation , 2000, Molecular and Cellular Biology.

[50]  T. Owens,et al.  IFN-γ Shapes Immune Invasion of the Central Nervous System Via Regulation of Chemokines1 , 2000, The Journal of Immunology.

[51]  J. Tschopp,et al.  Caspase Activation Is Required for T Cell Proliferation , 1999, The Journal of experimental medicine.

[52]  A. Chinnaiyan,et al.  A role for FADD in T cell activation and development. , 1998, Immunity.

[53]  A. Cross,et al.  Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system. , 1997, Journal of immunology.

[54]  V. Kuchroo,et al.  Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis. , 1997, Journal of immunology.

[55]  N. Jenkins,et al.  Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand , 1994, Cell.

[56]  N. Copeland,et al.  Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis , 1992, Nature.

[57]  K. Honda,et al.  The contribution of transcription factor IRF1 to the interferon-γ–interleukin 12 signaling axis and TH1 versus TH-17 differentiation of CD4+ T cells , 2008, Nature Immunology.

[58]  Jianfei Yang,et al.  T-bet is a STAT1-induced regulator of IL-12R expression in naïve CD4+ T cells , 2002, Nature Immunology.

[59]  S. Gerondakis,et al.  NF-kappa B RelA (p65) is essential for TNF-alpha-induced fas expression but dispensable for both TCR-induced expression and activation-induced cell death. , 2001, Journal of immunology.

[60]  R. Eisenberg,et al.  Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. , 1991, Annual review of immunology.

[61]  V. Kuchroo,et al.  Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease. , 2004, The Journal of clinical investigation.

[62]  R. Tsien,et al.  Specificity and Stability in Topology of Protein Networks , 2022 .